ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.65
-0.26%
US Tech 100
19,168.00
0.52%
S&P 500
5,431.60
-0.04%
US Dollar vs CAD
1.37515
0.00%
Bitcoin
66,542.01
0.53%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Corcept Therapeutics Inc (CORT)

  7. Corcept Therapeutics Inc (CORT) News

CORT Corcept Therapeutics Inc

28.97
-2.54 (-8.06%)
Jun 14 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Corcept Therapeutics Inc CORT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-2.54 -8.06% 28.97 23:00:03
Open Price Low Price High Price Close Price Previous Close
31.19 28.26 31.19 28.97 31.51
more quote information »

Recent News

Date Time Source Heading
6/06/202417:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/05/202420:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/05/202420:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/05/202420:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/05/202420:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/05/202420:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/05/202420:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/03/202413:15EDGAR2Form 144 - Report of proposed sale of securities
6/03/202413:05EDGAR2Form 144 - Report of proposed sale of securities
6/03/202412:05EDGAR2Form 144 - Report of proposed sale of securities
6/03/202407:00GLOBECorcept Therapeutics Announces Presentations of Results of..
5/31/202415:47EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202415:46EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202415:45EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202415:44EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202415:43EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202415:41EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202415:40EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202415:39EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202415:38EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202415:38EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202415:38EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202415:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
5/30/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/30/202419:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/28/202418:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/28/202412:22EDGAR2Form 144 - Report of proposed sale of securities
5/28/202412:14EDGAR2Form 144 - Report of proposed sale of securities
5/28/202407:00GLOBECorcept Announces Primary Endpoint Met in Pivotal Phase 3..
5/23/202415:11EDGAR2Form 8-K - Current report
5/21/202417:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202417:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202417:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202417:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202417:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202417:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202417:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/15/202419:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/13/202420:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/13/202411:24EDGAR2Form 144 - Report of proposed sale of securities
5/09/202411:35EDGAR2Form 144 - Report of proposed sale of securities
5/06/202419:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/01/202415:05GLOBECorcept Therapeutics Announces First Quarter Financial..
4/29/202407:00GLOBECorcept Completes Enrollment in Phase 4 CATALYST Trial
4/24/202415:05GLOBECorcept Therapeutics to Announce First Quarter Financial..
4/22/202407:00GLOBECorcept Announces Positive Results From Open-Label Portion..
4/15/202407:00GLOBECorcept Completes Enrollment in Phase 2 DAZALS Trial in..
4/08/202407:00GLOBECorcept Completes Enrollment in Pivotal Phase 3 Rosella..
4/01/202407:00GLOBECorcept Completes Enrollment in Phase 3 Gradient Trial of..

Your Recent History

NASDAQ
CORT
Corcept Therapeutics
NASDAQ
SCLN
Sciclone
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved